Statlife is an innovative company specializing in statistics and data mining applied to Predictive and Preventive Personalized Participative (4P Medicine). MammoRisk, a tool designed for breast cancer assessment, was developed in collaboration with Gustave-Roussy, the biggest comprehensive Cancer Center in Europe, and the BCSC in US. MammoRisk is the subject of a patent application using the "Nearest Neighbor" methodology for the prediction of disease (patent number: EP2278510). Headquartered in Paris, France, with an office in Boston, MA, Statlife is a medical software company specializing in statistical data mining using the 4P Medicine principle: Predictive, Preventive, Personalized, and Participative. MammoRisk, an assessment tool designed to calculate breast cancer risk, was developed in collaboration with Intitut Gustave-Roussy, the largest comprehensive Cancer Center in Europe, and the Breast Cancer Screening Center (BCSC) in the United States. MammoRisk is the subject of a patent application using the "Known Nearest Neighbor" methodology for the prediction of disease (Patent Number: EP2278510). MammoRisk is CE Marked and is FDA approved.